Articles tagged with Viral Infections
Researchers tested Zika virus in human neural stem cells to understand its effects on developing brains. The study found that the virus preferentially killed brain cells, reducing growth by 40% in a brain organoid model.
Researchers found that exposure to cigarette smoke and flu viruses reduces the effectiveness of common COPD medication salbutamol. A new model could help identify alternative treatments for patients with these symptoms.
Researchers from the University of Cambridge found that diagnostic tests are crucial for forecasting major epidemics. The study shows that precise estimates of infected individuals cannot be inferred from data based on symptomatic cases alone, highlighting the need for reliable diagnostic tests to detect presymptomatic infections.
A novel virus, Tilapia Lake Virus (TiLV), has been identified as the cause of massive tilapia die-offs in Israel and Ecuador, with significant implications for the global aquaculture industry. The discovery provides critical genomic and protein sequences necessary for disease detection, containment, and vaccine development.
Researchers discovered a new fish virus, Tilapia Lake Virus (TiLV), causing mass die-offs in Ecuador and Israel, affecting wild and farmed tilapia populations. The team identified the virus's genetic sequence and showed it replicates in fish cells, providing a foundation for developing a vaccine.
Researchers have established a mouse model that mimics aspects of Zika virus infection in humans, allowing for the testing of vaccines and therapeutics. The model shows high levels of the virus in the brain, spinal cord, and testes of male mice, supporting clinical data on sexual transmission.
A team of NIH doctors detailed a severe case of Ebola virus disease involving the central nervous system. Despite multi-organ failure, the patient survived with intensive supportive care, highlighting near complete recovery is possible with such care alone.
A study published in JAMA Internal Medicine found that quality of care varied significantly among eight commercial virtual visit companies, with differences in diagnosis accuracy and adherence to guidelines. The variation was greater for certain conditions, such as viral pharyngitis and acute rhinosinusitis.
Researchers have successfully developed a new treatment for the deadly Junin virus, providing complete protection against the disease. The laboratory-engineered antibody demonstrated effectiveness in guinea pigs and showed promise as a therapeutic solution for patients.
Researchers have determined the near-atomic level map of Zika virus, showing a notable difference in one key surface protein compared to other flaviviruses like dengue. This structure may provide clues for understanding how Zika enters human cells and suggest ways to combat the virus with drugs or vaccines.
A novel vaccine strategy has been developed to provide both short-term and long-term protection against the Chikungunya virus. The strategy combines a non-viral, vector-based monoclonal antibody delivery method with a DNA-based vaccine approach.
Coral reefs in the South China Sea are facing severe damage due to dredging and land reclamation. The study reveals that seven atolls have lost ~11.6 km2 of reef area while gaining ~10.7 km2 of land between 2014 and 2015. The researchers call for international cooperation to conserve this critical ecosystem.
A recent poll by Harvard T.H. Chan School of Public Health found that four in 10 people mistakenly believe Zika virus infection in women is likely to harm future pregnancies. The general public also has misperceptions about Zika virus transmission, including incorrect beliefs about symptoms and transmission methods.
Researchers at the University of Kent have identified a new form of Ebolavirus that may cause human disease. The study suggests that only a few changes in a specific protein are necessary to render the Reston virus into a health threat.
A new study maps the global spread of Zika, linking it to two mosquito species that can effectively carry the disease, including Aedes aegypti and Aedes albopictus. Cities in the US, Europe, and Asia are at risk, with Miami and Houston among the highest-risk areas.
A study in Proceedings of the National Academy of Sciences identified biological factors predicting viral transmission efficiency among humans. Low host mortality and extended survival time increase a virus's ability to spread, while envelope structures and insect vectors hinder emergence.
The Zika virus poses a significant threat to West Africa, particularly in Liberia, Sierra Leone, and Guinea, due to the recent Ebola outbreak. Rapid testing for Zika is crucial to prevent confusion between Zika and early Ebola symptoms.
Research predicts increased suitability for Aedes aegypti mosquitoes in southern and eastern US cities, leading to potential Zika outbreaks. Warm weather conditions facilitate mosquito populations, especially in April, June, July, August, and September.
Researchers found that viruses opt for 'piggyback-the-winner' strategy, integrating into hosts to reduce replication and avoid immunity defenses. This model better explains virus-host dynamics during microbial population booms.
Researchers found a promising single-dose dengue vaccine effective in preventing human volunteers from contracting the virus, protecting against infection. The study's findings could be the final piece in developing an effective vaccine against dengue, which infects nearly 400 million people annually.
Researchers at the University of Vermont and National Institutes of Health have developed a highly effective dengue vaccine requiring only one dose. The vaccine has shown promise in protecting against all four dengue strains, with no adverse reactions reported among test subjects.
A controlled human challenge study shows a dengue vaccine candidate can fully protect healthy volunteers from infection. The results support further evaluation of the vaccine and may help identify promising candidates and eliminate poor ones.
Researchers have found that the RNA virus bovine viral diarrhea virus relies on host miRNAs, specifically miR-17 and let-7, to replicate. Inhibiting this interaction may provide an effective target for developing new drugs to control BVDV.
Researchers at the University of Edinburgh found a compound called cathelicidin that directly attacks and stops RSV from binding to cells. Boosting natural production of this compound could protect babies and vulnerable adults from life-threatening illnesses.
A study by UCLA researchers found associations between Zika infection and grave outcomes, including fetal death, placental insufficiency, and central nervous system damage. The study suggests that Zika can cause a range of abnormalities in pregnant women, even if the fetus is not directly affected.
Researchers have found that Zika virus infects a type of neural stem cell responsible for brain development, leading to cell death and disruption of growth. The study provides new insights into the potential effects of Zika on neural tissue and may lead to the development of therapeutics.
A Johns Hopkins Medicine research team found that Zika virus selectively infects and kills cells in the brain's cortex, leading to disruptions in cell division and growth. This discovery using lab-grown stem cells may lead to identifying potential therapies for protecting these susceptible cells.
A study has created global maps showing the geographical limits of chikungunya and dengue viruses, highlighting a rapid expansion in chikungunya's global extent. The research emphasizes the need for improved diagnostic tests and clear protocols for controlling both diseases.
The Zika Response Working Group provides recommendations for countermeasures against the Zika virus, highlighting the need for open-minded responses and collaboration. Key findings include the potential of currently marketed drugs to have anti-Zika activity and the challenges of rapid vaccine development.
The risk of catching Ebola from a survivor is very low, with most body fluids cleared within weeks apart from semen. Studies found that infected blood is the most infectious, but social contact poses little risk.
Researchers have identified the three-dimensional structure of a hantavirus protein, providing a promising model for developing drugs against the disease. The protein's circular complexes may play a role in inhibiting viral growth, making it an ideal target for future treatments.
The Zika virus has been linked to neurological diseases, with estimated 1.5 million cases reported so far. Researchers are urging a rigorous approach to understanding the effects of the virus and developing treatment measures.
Researchers from Colorado State University have discovered a potential diagnostic tool for dengue fever by analyzing metabolomic profiles in patient serum. The study found that distinct metabolic clusters were associated with different disease outcomes, including the progression to hemorrhagic fever/dengue shock syndrome.
A single monoclonal antibody isolated from an Ebola survivor protected non-human primates even after lethal infection, offering hope for a potential treatment. The findings suggest a novel site of vulnerability on the Ebola virus and may lead to effective therapy.
A single monoclonal antibody isolated from a human Ebola survivor has been shown to completely protect monkeys from lethal infection with the virus. The antibody, known as mAb114, was effective even when given five days after exposure, suggesting it could be used as a potential treatment for human cases.
Researchers discovered two potent Ebola antibodies that eliminate symptoms in just five days after infection. The monoclonal antibodies target different regions of the virus's glycoprotein and work by interfering with its entry into host cells.
Researchers propose a novel framework to uncover hidden patterns of transmission and identify super spreaders in epidemics. Asymptomatic carriers can play a significant role in spreading diseases, and understanding their contribution is crucial for targeted interventions.
Recent gene therapy developments focus on viral vectors like AAV for safe gene transfer, and new gene editing tools offer targeted gene inactivation or insertion. These approaches aim to treat multiple diseases with platform strategies.
A recent study by the American Academy of Neurology has found that most Ebola survivors experienced brain symptoms six months after their initial infection. The study, which followed 82 Ebola survivors from Liberia, revealed common neurological problems such as weakness, headache, memory loss, and depressed mood.
Scientists have successfully altered the genetic code of pigs to make them more resilient to African Swine Fever. By modifying a specific gene, researchers believe they may be able to reduce the disease's devastating effects on infected animals.
ZMapp, a monoclonal antibody cocktail, was well-tolerated and showed promise in treating Ebola virus disease. The trial's results indicate that patients who received ZMapp appeared to do better than those who received standard-of-care only, but the difference was not statistically significant.
A study of Ebola survivors found high rates of eye, musculoskeletal, and neurological complications. The study also explored the risk of sexual transmission of Ebola, with most survivors reporting regular sexual activity but few using condoms.
Researchers have developed a method to make mosquitoes resistant to arboviruses like Dengue and Zika by introducing two strains of Wolbachia parasite. The superinfected mosquitoes showed improved virus inhibition and reduced transmission, making it a potential tool to combat mosquito-borne diseases.
Researchers at Virginia Tech have found a way to potentially track and stop viral outbreaks, including Hepatitis C in humans and plant viruses. By understanding how viruses replicate, they can develop new ways to control infection without causing host toxicity.
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health is studying tick-borne bacteria and viruses to better understand their role in human disease. The $1.9M grant will support research into potential pathogens, such as Borrelia burgdorferi, which causes Lyme disease.
Researchers from the University of Pennsylvania School of Veterinary Medicine have identified how the parasite <em>Toxoplasma gondii</em> infects the brain by tracking its movement and reproduction in living tissues. The study provides insights into treatment strategies to combat the parasite, which can be life-threatening for people w...
A study published in PNAS reveals that genetic variations in the Tie2 gene are associated with an increased risk of developing life-threatening vascular complications following infections. Higher Tie2 levels provide protection against these complications.
The DengueTools consortium has accumulated knowledge on controlling the spread of Dengue fever by targeting its mosquito carriers. The global collaboration aims to develop practical tools for diagnosing and monitoring the virus in affected areas, as well as prevent infections in school children.
A distinctive gene signature discovered in white blood cells of patients infected with Lyme disease could lead to a new way of diagnosing the tick-borne illness. The study found that this signature persisted even after antibiotic treatment, suggesting potential long-term symptoms.
Researchers developed a real-time system to track Ebola virus particles' interaction with human cells, revealing crucial host and viral proteins involved in fusion. The study identifies specific cellular proteins required for fusion, offering insights into designing future drugs or vaccines.
Researchers discovered a novel mechanism by which adenovirus protein E4orf4 inhibits the DNA damage response, improving viral replication. This finding provides insight into the virus's ability to infect immunocompromised patients and may lead to new cancer therapies.
Scientists at Indiana University have developed a method to alter a plant's innate defense system to deliver resistance to a new disease. By creating decoy proteins that mimic bacterial modifications, the team broadened the recognition ability of a sensor protein to detect multiple pathogens.
A report published in Annals of Internal Medicine describes the first known case of Zika virus in a US resident following travel to Costa Rica. The traveler exhibited symptoms and had test results that indicated Zika infection, highlighting the need for travelers to avoid day-biting mosquitoes.
A Brazilian study found a link between Zika virus and eye abnormalities in infants with microcephaly. The study evaluated 29 infants with microcephaly and found ophthalmoscopic abnormalities in 34.5% of them, including focal pigment mottling of the retina and chorioretinal atrophy.
The Zika virus is primarily transmitted by Aedes mosquitoes, which also spread dengue and chikungunya viruses. Physicians should be aware of symptoms in travelers returning from affected regions and consider Guillain-Barré syndrome and microcephaly as potential complications.
Zika virus, a mosquito-borne disease, can cause microcephaly in infants and mild flu-like symptoms in adults and children. The US is at risk of introduction, particularly with the presence of Aedes species mosquitoes in many states.
A comprehensive review reveals frequent opportunities for HCV exposure in Ghana, including traditional practices like circumcision and home births. The study found a substantial genetic diversity of HCV-2, confirming its long epidemic history in the country.
A study found that lower respiratory tract infections, such as pneumonia, account for 26 percent of all ER visits for infectious diseases and 15 percent of deaths during hospitalizations. Influenza vaccination is underutilized among older adults, with about one-third not receiving the vaccine.
Two vector-borne diseases, Chagas' disease and Leishmaniasis, can be transmitted from mother to child through the placenta, posing a significant risk to newborns. Research highlights the importance of healthcare workers remembering these diseases when examining sick children whose mothers have traveled from affected areas.
Researchers found that immune cells activated during severe maternal inflammation produce IL-17, which interferes with brain development. Blocking this signal restored normal behavior and brain structure in mice. The study suggests a possible mechanism for how maternal infection may lead to autism-like behavior.